A new article on G2 Intelligence outlined the effect that the Supreme Court’s ruling on the Patient Protection and Affordable Care Act will have on labs.

“For labs, one benefit is that the law requires Medicare and private health plans to fully cover the cost of preventive services, including screening tests, that are rated A or B by the U.S. Preventive Services Task Force… However, Dennis Weissman, an industry expert and founder of Washington G-2 Reports (now G2 Intelligence), cautions that the impact on providers is not entirely clear.”

To read the entire article, click here.

Source: G2 Intelligence